International Union of Basic and Clinical Pharmacology. CVII. Structure and Pharmacology of the Apelin Receptor with a Recommendation that Elabela/Toddler Is a Second Endogenous Peptide Ligand
Tóm tắt
Từ khóa
Tài liệu tham khảo
Aboouf, 2015, Genotype screening of APLN rs3115757 variant in Egyptian women population reveals an association with obesity and insulin resistance, Diabetes Res Clin Pract, 109, 40, 10.1016/j.diabres.2015.05.016
Akcılar, 2015, The effects of apelin treatment on a rat model of type 2 diabetes, Adv Med Sci, 60, 94, 10.1016/j.advms.2014.11.001
Akcılar, 2015, APJ receptor A445C gene polymorphism in Turkish patients with coronary artery disease, Int J Clin Exp Med, 8, 18793
Akcılar, 2015, Characterization of the apelin -1860T>C polymorphism in Turkish coronary artery disease patients and healthy individuals, Int J Physiol Pathophysiol Pharmacol, 7, 165
Alipour, 2017, An overview on biological functions and emerging therapeutic roles of apelin in diabetes mellitus, Diabetes Metab Syndr, 11, S919, 10.1016/j.dsx.2017.07.016
Balkau, 1999, Insulin resistance: an independent risk factor for cardiovascular disease?, Diabetes Obes Metab, 1, S23, 10.1046/j.1463-1326.1999.0010s1023.x
Berry, 2004, Apelin has in vivo inotropic effects on normal and failing hearts, Circulation, 110, II187
Blanc, 2015, SwissPalm: protein palmitoylation database, F1000Res, 4, 261, 10.12688/f1000research.6464.1
Brash, 2018, Short-term hemodynamic effects of apelin in patients with pulmonary arterial hypertension, JACC Basic Transl Sci, 3, 176, 10.1016/j.jacbts.2018.01.013
Castan-Laurell, 2019, The apelin/APJ system as a therapeutic target in metabolic diseases, Expert Opin Ther Targets, 23, 215, 10.1080/14728222.2019.1561871
Chapman, 2014, The apelin receptor: physiology, pathology, cell signalling, and ligand modulation of a peptide-activated class A GPCR, Biochem Cell Biol, 92, 431, 10.1139/bcb-2014-0072
Chen, 2015, Apelin protects against acute renal injury by inhibiting TGF-β1, Biochim Biophys Acta, 1852, 1278, 10.1016/j.bbadis.2015.02.013
Chen N Chen X Chen Y Cheng AC Connors RV Deignan J Dransfield PJ Du X Fu Z Heath JA (2017b) Triazole agonists of the APJ receptor. Patent WO2016187308A1. 2016 May 18.
Chen, 2017, Association of apelin and apelin receptor with the risk of coronary artery disease: a meta-analysis of observational studies, Oncotarget, 8, 57345, 10.18632/oncotarget.17360
Chen, 2016, Apelin/APJ system: a novel therapeutic target for myocardial ischemia/reperfusion injury, DNA Cell Biol, 35, 766, 10.1089/dna.2016.3391
Cheng, 2019, Apelin/APJ system: a potential therapeutic target for endothelial dysfunction-related diseases, J Cell Physiol, 234, 12149, 10.1002/jcp.27942
Choe, 1998, The orphan seven-transmembrane receptor apj supports the entry of primary T-cell-line-tropic and dualtropic human immunodeficiency virus type 1, J Virol, 72, 6113, 10.1128/JVI.72.7.6113-6118.1998
Chun, 2008, Apelin signaling antagonizes Ang II effects in mouse models of atherosclerosis, J Clin Invest, 118, 3343
Davenport, 2018, First in human study of a novel biased apelin receptor ligand, MM54, a G-alpha(i) agonist/beta-arrestin antagonist (Abstract), Circ Res, 123, E70
Deshwar, 2016, The apelin receptor enhances Nodal/TGFβ signaling to ensure proper cardiac development, eLife, 5, e13758, 10.7554/eLife.13758
Edinger, 1998, An orphan seven-transmembrane domain receptor expressed widely in the brain functions as a coreceptor for human immunodeficiency virus type 1 and simian immunodeficiency virus, J Virol, 72, 7934, 10.1128/JVI.72.10.7934-7940.1998
Falcone, 2012, APJ polymorphisms in coronary artery disease patients with and without hypertension, Mol Med Rep, 5, 321
Fan, 2015, The apelin-APJ axis is an endogenous counterinjury mechanism in experimental acute lung injury, Chest, 147, 969, 10.1378/chest.14-1426
Fan, 2015, Treatment with metformin and a dipeptidyl peptidase-4 inhibitor elevates apelin levels in patients with type 2 diabetes mellitus, Drug Des Devel Ther, 9, 4679, 10.2147/DDDT.S85740
Flahault, 2017, Role of the vasopressin/apelin balance and potential use of metabolically stable apelin analogs in water metabolism disorders, Front Endocrinol (Lausanne), 8, 120, 10.3389/fendo.2017.00120
Freyer, 2017, Loss of apela peptide in mice causes low penetrance embryonic lethality and defects in early mesodermal derivatives, Cell Rep, 20, 2116, 10.1016/j.celrep.2017.08.014
Ganguly, 2019, APELA expression in glioma, and its association with patient survival and tumor grade, Pharmaceuticals (Basel), 12, 1, 10.3390/ph12010045
Gilbert, 2017, From apelin to exercise: emerging therapies for management of hypertension in pregnancy, Hypertens Res, 40, 519, 10.1038/hr.2017.40
Golosov A Grosche P Hu QY Imase H Parker DT Yasoshima K Zecri F Zhao H (2013) Synthetic apelin mimetics for the treatment of heart failure. Patent WO2013111110A3. 2013 Jan 25.
Gourdy, 2018, Apelin administration improves insulin sensitivity in overweight men during hyperinsulinaemic-euglycaemic clamp, Diabetes Obes Metab, 20, 157, 10.1111/dom.13055
Guo, 2015, Apelin promotes diabetic nephropathy by inducing podocyte dysfunction via inhibiting proteasome activities, J Cell Mol Med, 19, 2273, 10.1111/jcmm.12619
Gupta, 2016, Biochemical and genetic role of apelin in essential hypertension and acute coronary syndrome, Int J Cardiol, 223, 374, 10.1016/j.ijcard.2016.07.242
Habata, 1999, Apelin, the natural ligand of the orphan receptor APJ, is abundantly secreted in the colostrum, Biochim Biophys Acta, 1452, 25, 10.1016/S0167-4889(99)00114-7
Hachtel S Wohlfart P Weston J Müller M Defossa E Mertsch K Weng J Binnie RA Abdul-Latif F Bock WJ (2014) Benzoimidazole-carboxylic acid amide derivatives as APJ receptor modulators. Patent WO2014044738A1. 2013 Sep 19.
Hamada, 2008, Evaluation of novel cyclic analogues of apelin, Int J Mol Med, 22, 547
Harford-Wright, 2017, Pharmacological targeting of apelin impairs glioblastoma growth, Brain, 140, 2939, 10.1093/brain/awx253
Hata, 2011, Genome-wide association study for ischemic stroke based on the Hisayama study, Nihon Eiseigaku Zasshi, 66, 47, 10.1265/jjh.66.47
Helker, 2015, The hormonal peptide Elabela guides angioblasts to the midline during vasculogenesis, eLife, 4, 6726, 10.7554/eLife.06726
Hinohara, 2009, Validation of the association between AGTRL1 polymorphism and coronary artery disease in the Japanese and Korean populations, J Hum Genet, 54, 554, 10.1038/jhg.2009.78
Hu, 2016, Apelin/APJ system as a therapeutic target in diabetes and its complications, Mol Genet Metab, 119, 20, 10.1016/j.ymgme.2016.07.012
Huang, 2016, Associations between gene polymorphisms of the apelin-APJ system and the risk of hypertension, Blood Press, 25, 257, 10.3109/08037051.2016.1156905
Huang, 2016, The apelin-APJ axis: a novel potential therapeutic target for organ fibrosis, Clin Chim Acta, 456, 81, 10.1016/j.cca.2016.02.025
Huang, 2018, Apelin/APJ system: a novel potential therapy target for kidney disease, J Cell Physiol, 233, 3892, 10.1002/jcp.26144
Hutchings, 2017, Opportunities for therapeutic antibodies directed at G-protein-coupled receptors, Nat Rev Drug Discov, 16, 661, 10.1038/nrd.2017.173
Jia, 2015, Apelin polymorphism predicts blood pressure response to losartan in older Chinese women with essential hypertension, Genet Mol Res, 14, 6561, 10.4238/2015.June.12.10
Juhl, 2016, Development of potent and metabolically stable APJ ligands with high therapeutic potential, ChemMedChem, 11, 2378, 10.1002/cmdc.201600307
Kawamata, 2001, Molecular properties of apelin: tissue distribution and receptor binding, Biochim Biophys Acta, 1538, 162, 10.1016/S0167-4889(00)00143-9
Khan P Maloney PR Hedrick M Gosalia P Milewski M Li L Roth GP Sergienko E Suyama E Sugarman E (2011) Functional agonists of the apelin (APJ) receptor. Probe Reports from the NIH Molecular Libraries Program, National Center for Biotechnology Information, Bethesda, MD.
Kocer, 2016, Evaluation of fibrosis markers: apelin and transforming growth factor-β1 in autosomal dominant polycystic kidney disease patients, Ther Apher Dial, 20, 517, 10.1111/1744-9987.12412
Kotanidou, 2015, Apelin and G212A apelin receptor gene polymorphism in obese and diabese youth, Pediatr Obes, 10, 213, 10.1111/ijpo.251
Kuba, 2019, Apelin and Elabela/Toddler; double ligands for APJ/Apelin receptor in heart development, physiology, and pathology, Peptides, 111, 62, 10.1016/j.peptides.2018.04.011
Kumar, 2016, Apelin binding to human APJ receptor leads to biased signaling, Biochim Biophys Acta, 1864, 1748, 10.1016/j.bbapap.2016.09.012
Langelaan, 2013, Structural features of the apelin receptor N-terminal tail and first transmembrane segment implicated in ligand binding and receptor trafficking, Biochim Biophys Acta, 1828, 1471, 10.1016/j.bbamem.2013.02.005
Li, 2016, A promoter polymorphism in APJ gene is significantly associated with blood pressure changes and hypertension risk in Chinese women, Oncotarget, 7, 86257, 10.18632/oncotarget.13370
Lin, 2015, GSK2374697, a long duration glucagon-like peptide-1 (GLP-1) receptor agonist, reduces postprandial circulating endogenous total GLP-1 and peptide YY in healthy subjects, Diabetes Obes Metab, 17, 1007, 10.1111/dom.12533
Luo, 2018, Apelin/APJ system: a critical regulator of vascular smooth muscle cell, J Cell Physiol, 233, 5180, 10.1002/jcp.26339
Lv, 2017, Apelin/APJ system: a key therapeutic target for liver disease, Oncotarget, 8, 112145, 10.18632/oncotarget.22841
Ma, 2014, Plasma apelin: a novel biomarker for predicting diabetes, Clin Chim Acta, 435, 18, 10.1016/j.cca.2014.03.030
Macaluso, 2010, Exploring the ‘RPRL’ motif of apelin-13 through molecular simulation and biological evaluation of cyclic peptide analogues, ChemMedChem, 5, 1247, 10.1002/cmdc.201000061
Margathe, 2014, Structure-activity relationship studies toward the discovery of selective apelin receptor agonists, J Med Chem, 57, 2908, 10.1021/jm401789v
McAnally, 2017, A systematic approach to identify biased agonists of the apelin receptor through high-throughput screening, SLAS Discov, 22, 867, 10.1177/2472555217699158
McKeown, 2014, The design and implementation of a generic lipopeptide scanning platform to enable the identification of ‘locally acting’ agonists for the apelin receptor, Bioorg Med Chem Lett, 24, 4871, 10.1016/j.bmcl.2014.08.045
McKinnie, 2016, The metalloprotease neprilysin degrades and inactivates apelin peptides, ChemBioChem, 17, 1495, 10.1002/cbic.201600244
Murza, 2015, C-Terminal modifications of apelin-13 significantly change ligand binding, receptor signaling, and hypotensive action, J Med Chem, 58, 2431, 10.1021/jm501916k
Murza, 2016, Discovery and structure-activity relationship of a bioactive fragment of elabela that modulates vascular and cardiac functions, J Med Chem, 59, 2962, 10.1021/acs.jmedchem.5b01549
Murza, 2017, Structure-activity relationship of novel macrocyclic biased apelin receptor agonists, Org Biomol Chem, 15, 449, 10.1039/C6OB02247B
Myers MC Lawrence RM Bilder DM Meng W Pi Z Brigance RP Finlay H (2017) Heteroarylhydroxypyrimidinones as agonists of the APJ receptor. Patent WO2017106396A1. 2016 Dec 15.
Narayanan, 2016, Discovery of a novel small molecule agonist scaffold for the APJ receptor, Bioorg Med Chem, 24, 3758, 10.1016/j.bmc.2016.06.018
Nyimanu, 2018, The apelin-36 mutant peptide N-58 (apelin 36-[l28A]) and its pegylated analogue N-140 (apelin 36-[L2c-30kDa-PEG) that mediate beneficial metabolic actions are G-protein biased ligands at the apelin receptor (Abstract), Circulation, 138, 15595
O’Carroll, 2000, Distribution of mRNA encoding B78/apj, the rat homologue of the human APJ receptor, and its endogenous ligand apelin in brain and peripheral tissues, Biochim Biophys Acta, 1492, 72, 10.1016/S0167-4781(00)00072-5
O’Harte, 2018, Long-term treatment with acylated analogues of apelin-13 amide ameliorates diabetes and improves lipid profile of high-fat fed mice, PLoS One, 13, e0202350, 10.1371/journal.pone.0202350
O’Harte, 2018, Apelin-13 analogues show potent in vitro and in vivo insulinotropic and glucose lowering actions, Peptides, 100, 219, 10.1016/j.peptides.2017.12.004
Pakizeh, 2015, The assessment of the relationship between variations in the apelin gene and coronary artery disease in Turkish population, Anatol J Cardiol, 15, 716, 10.5152/akd.2014.5685
Pang, 2014, Effect of apelin on the cardiac hemodynamics in hypertensive rats with heart failure, Int J Mol Med, 34, 756, 10.3892/ijmm.2014.1829
Perjés, 2016, Characterization of apela, a novel endogenous ligand of apelin receptor, in the adult heart, Basic Res Cardiol, 111, 2, 10.1007/s00395-015-0521-6
Pinkerton AB Smith LH (2015) Agonists of the apelin receptor and methods of use thereof. Patent WO2015184011A2. 2015 May 27.
Pisarenko, 2015, Structural apelin analogues: mitochondrial ROS inhibition and cardiometabolic protection in myocardial ischaemia reperfusion injury, Br J Pharmacol, 172, 2933, 10.1111/bph.13038
Pisarenko, 2015, Signaling pathways of a structural analogue of apelin-12 involved in myocardial protection against ischemia/reperfusion injury, Peptides, 73, 67, 10.1016/j.peptides.2015.09.001
Pope, 2016, Agonist-induced internalization and desensitization of the apelin receptor, Mol Cell Endocrinol, 437, 108, 10.1016/j.mce.2016.07.040
Read C Fitzpatrick CM Yang P Kuc RE Nyimanu D Maguire JJ Glen RC Foster R Davenport AP (2017) CMF-019, the first G protein biased small molecule apelin agonist, is a vasodilator and positive inotrope in vivo (Abstract), in APSA-ASCEPT 2017 Joint Scientific Meeting; 2017 December 5-8; Brisbane, Australia. pp 33, APSA-ASCEPT.
Read C Yang P Kuc RE Nyimanu D Williams TL Glen RC Holt LJ Arulanantham H Smart A Davenport AP (2019) Apelin peptides linked to anti-serum albumin domain antibodies retain affinity in vitro and are efficacious receptor agonists in vivo. Basic Clin Pharmacol Toxicol DOI: 1111/bcpt.13227 [published ahead of print].
Sato, 2017, ELABELA-APJ axis protects from pressure overload heart failure and angiotensin II-induced cardiac damage, Cardiovasc Res, 113, 760, 10.1093/cvr/cvx061
Schreiber, 2017, Sustained ELABELA gene therapy in high-salt diet-induced hypertensive rats, Curr Gene Ther, 16, 349, 10.2174/1566523217666161121111906
Serpooshan, 2015, [Pyr1]-Apelin-13 delivery via nano-liposomal encapsulation attenuates pressure overload-induced cardiac dysfunction, Biomaterials, 37, 289, 10.1016/j.biomaterials.2014.08.045
Soualmia, 2017, The A445C variant in apelin receptor and diabetic retinopathy in Tunisian patients, Clin Lab, 63, 379, 10.7754/Clin.Lab.2016.160424
Thenappan, 2018, Role of extracellular matrix in the pathogenesis of pulmonary arterial hypertension, Am J Physiol Heart Circ Physiol, 315, H1322, 10.1152/ajpheart.00136.2018
Trifonov, 2018, An expedient synthesis of CMF-019: (S)-5-methyl-3-{1-(pentan-3-yl)-2- (thiophen-2-ylmethyl)-1H-benzo[d]imidazole-5-carboxamido}hexanoic acid, a potent apelin receptor (APJ) agonist, Med Chem, 14, 688, 10.2174/1573406414666180412154952
Turecek, 2016, PEGylation of biopharmaceuticals: a review of chemistry and nonclinical safety information of approved drugs, J Pharm Sci, 105, 460, 10.1016/j.xphs.2015.11.015
Velazquez, 2019, Angiotensin-neprilysin inhibition in acute decompensated heart failure, N Engl J Med, 380, 539, 10.1056/NEJMoa1812851
Wang, 2014, The regulatory peptide apelin: a novel inhibitor of renal interstitial fibrosis, Amino Acids, 46, 2693, 10.1007/s00726-014-1826-8
Wang, 2013, Effects of acute intravenous infusion of apelin on left ventricular function in dogs with advanced heart failure, J Card Fail, 19, 509, 10.1016/j.cardfail.2013.05.004
Wang, 2015, Association of SNP Rs9943582 in APLNR with left ventricle systolic dysfunction in patients with coronary artery disease in a Chinese han GeneID population, PLoS One, 10, e0125926, 10.1371/journal.pone.0125926
Wang, 2015, Elabela-apelin receptor signaling pathway is functional in mammalian systems, Sci Rep, 5, 8170, 10.1038/srep08170
Wu, 2017, Apelin/APJ system: a novel promising therapy target for pathological angiogenesis, Clin Chim Acta, 466, 78, 10.1016/j.cca.2016.12.023
Yang, 2017, [Pyr1]apelin-13(1-12) is a biologically active ACE2 metabolite of the endogenous cardiovascular peptide [Pyr1]apelin-13, Front Neurosci, 11, 92, 10.3389/fnins.2017.00092
Yang, 2019, A novel cyclic biased agonist of the apelin receptor, MM07, is disease modifying in the rat monocrotaline model of pulmonary arterial hypertension, Br J Pharmacol, 176, 1206, 10.1111/bph.14603
Yang, 2015, Apelin-13 protects the heart against ischemia-reperfusion injury through the RISK-GSK-3β-mPTP pathway, Arch Med Sci, 11, 1065
Yi, 2017, APELA promotes tumour growth and cell migration in ovarian cancer in a p53-dependent manner, Gynecol Oncol, 147, 663, 10.1016/j.ygyno.2017.10.016
Zhang, 2017, A Study of GWAS-supported variants of rs9943582 in a Chinese Han population with ischemic stroke: no associations with disease onset and clinical outcomes, J Stroke Cerebrovasc Dis, 26, 2294, 10.1016/j.jstrokecerebrovasdis.2017.05.013
Zhang, 2016, Apelin as a marker for monitoring the tumor vessel normalization window during antiangiogenic therapy, Cancer Sci, 107, 36, 10.1111/cas.12836
Zhang, 2009, Association of apelin genetic variants with type 2 diabetes and related clinical features in Chinese Hans, Chin Med J (Engl), 122, 1273
Zhang, 1998, Use of coreceptors other than CCR5 by non-syncytium-inducing adult and pediatric isolates of human immunodeficiency virus type 1 is rare in vitro, J Virol, 72, 9337, 10.1128/JVI.72.11.9337-9344.1998
Zheng, 2016, The association between single nucleotide polymorphisms of the apelin gene and diabetes mellitus in a Chinese population, J Pediatr Endocrinol Metab, 29, 1397, 10.1515/jpem-2015-0441
Zhou, 2017, Effects of apelin on cardiovascular aging, Front Physiol, 8, 1035, 10.3389/fphys.2017.01035
Zhu, 2015, Apelin and APLN single nucleotide polymorphisms and combined hypertension and central retinal artery stenosis in a Chinese population, Clin Exp Hypertens, 37, 280, 10.3109/10641963.2014.960970